The Israel Tech & Innovation News site, NoCamels, releases front-page feature about NOL based on interview with Medasense CEO & Founder, Galit Zuckerman.
Newsdesk
Follow Medasense’s accomplishments and news
NoCamels publishes article on the benefits of nociception monitoring with the NOL Technology
Top Posts
FDA Commissioner Highlights Marketing Authorization of NOL Technology
September 21, 2023
Now in the U.S. – Meet us at U.S. conferences
August 30, 2023
Pain News Network publishes article on Medasense
April 13, 2023